Literature DB >> 17279591

Bivalent peptides as models for multimeric targets of PDZ domains.

Marcin Paduch1, Monika Biernat, Piotr Stefanowicz, Zygmunt S Derewenda, Zbigniew Szewczuk, Jacek Otlewski.   

Abstract

PDZ domains are among the most common modules in eukaryotic, including human, genomes. They are found exclusively in large, multidomain cytosolic proteins--often with other domains that belong to a variety of families--and are involved in a plethora of physiological and pathophysiological events. PDZ domains mediate protein-protein interactions by binding to solvent-exposed and extended C-terminal short fragments of membrane-associated proteins, such as receptors and ion channels. Most of what is known about the mechanisms of target binding by PDZ domains is inferred from studies that involve isolated recombinant PDZ domains and short synthetic peptides that represent the targets. These binary systems constitute an obvious oversimplification and disregard factors such as noncanonical modes of binding and enhanced affinity due to multimeric interactions mediated by clusters and oligomers of PDZ-domain-containing proteins. We have tested whether the interaction between a dimeric form of PDZ domain that mimics a functional dimeric guanine nucleotide exchange factor, PDZ-RhoGEF (PDZ-containing RhoA-specific guanine nucleotide exchange factor) or LARG (leukemia-associated RhoA specific guanine nucleotide exchange factor), and a bivalent peptide that mimics the dimer of the plexin B receptor, could enhance the interaction between the two moieties. Peptide dimerization was achieved by cross-linking the N-terminal ends of peptides attached to Wang resin with poly(ethylene glycol) spacers (30-45 Angstroms in length). The interaction of dimeric PDZ domains with dimeric peptides resulted in an up to 20-fold increase in affinity compared to the simple binary system. This is consistent with the notion that multimerization of both receptors and PDZ-containing proteins might constitute an important regulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279591     DOI: 10.1002/cbic.200600389

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  9 in total

1.  Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization.

Authors:  Matthieu Sainlos; Cezar Tigaret; Christel Poujol; Nelson B Olivier; Lucie Bard; Christelle Breillat; Kevin Thiolon; Daniel Choquet; Barbara Imperiali
Journal:  Nat Chem Biol       Date:  2010-12-26       Impact factor: 15.040

2.  Bivalent peptides as PDZ domain ligands.

Authors:  Edvin Klosi; Dorina Saro; Mark R Spaller
Journal:  Bioorg Med Chem Lett       Date:  2007-09-12       Impact factor: 2.823

3.  A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage.

Authors:  Anders Bach; Bettina H Clausen; Magda Møller; Bente Vestergaard; Celestine N Chi; Adam Round; Pernille L Sørensen; Klaus B Nissen; Jette S Kastrup; Michael Gajhede; Per Jemth; Anders S Kristensen; Patrik Lundström; Kate L Lambertsen; Kristian Strømgaard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-17       Impact factor: 11.205

4.  Deciphering the kinetic binding mechanism of dimeric ligands using a potent plasma-stable dimeric inhibitor of postsynaptic density protein-95 as an example.

Authors:  Celestine N Chi; Anders Bach; Marie Gottschalk; Anders S Kristensen; Kristian Strømgaard; Per Jemth
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

5.  Secondary PDZ domain-binding site on class B plexins enhances the affinity for PDZ-RhoGEF.

Authors:  Heath G Pascoe; Stephen Gutowski; Hua Chen; Chad A Brautigam; Zhe Chen; Paul C Sternweis; Xuewu Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

6.  Structural basis of PDZ-mediated chemokine receptor CXCR2 scaffolding by guanine nucleotide exchange factor PDZ-RhoGEF.

Authors:  Nicholas Spellmon; Joshua Holcomb; Andrea Niu; Vishakha Choudhary; Xiaonan Sun; Yingxue Zhang; Junmei Wan; Maysaa Doughan; Stephanie Hayden; Fatme Hachem; Joseph Brunzelle; Chunying Li; Zhe Yang
Journal:  Biochem Biophys Res Commun       Date:  2017-02-06       Impact factor: 3.575

7.  Conformational change upon ligand binding and dynamics of the PDZ domain from leukemia-associated Rho guanine nucleotide exchange factor.

Authors:  Jiangxin Liu; Jiahai Zhang; Yinshan Yang; Hongda Huang; Weiqun Shen; Qi Hu; Xingsheng Wang; Jihui Wu; Yunyu Shi
Journal:  Protein Sci       Date:  2008-04-14       Impact factor: 6.725

8.  Reconstitution of multivalent PDZ domain binding to the scaffold protein PSD-95 reveals ternary-complex specificity of combinatorial inhibition.

Authors:  James J McCann; Ucheor B Choi; Mark E Bowen
Journal:  Structure       Date:  2014-09-11       Impact factor: 5.006

9.  A high-affinity, bivalent PDZ domain inhibitor complexes PICK1 to alleviate neuropathic pain.

Authors:  Nikolaj R Christensen; Marta De Luca; Michael B Lever; Mette Richner; Astrid B Hansen; Gith Noes-Holt; Kathrine L Jensen; Mette Rathje; Dennis Bo Jensen; Simon Erlendsson; Christian Ro Bartling; Ina Ammendrup-Johnsen; Sofie E Pedersen; Michèle Schönauer; Klaus B Nissen; Søren R Midtgaard; Kaare Teilum; Lise Arleth; Andreas T Sørensen; Anders Bach; Kristian Strømgaard; Claire F Meehan; Christian B Vaegter; Ulrik Gether; Kenneth L Madsen
Journal:  EMBO Mol Med       Date:  2020-04-30       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.